Dexter JohnsonCOVID-19Plant offers potential for massive scale production of COVID-19 tests, vaccinesResearchers have developed a rapid and flexible agroinfiltration-based platform for the production of recombinant SARS-CoV-2 Spike Receptor-Binding Domain (RBD) in the benthi plant.December 16, 2022COVID-19Biomarkers present at initial COVID-19 infection hint at long COVIDThe researchers believe that these findings underscore the need for greater attention at the infection stage of COVID-19 to better understand the processes that eventually lead to long COVID.December 8, 2022COVID-19Long COVID patients at risk, whether hospitalized or notSpanish researchers reported that the percentage of patients with at least one post–COVID-19 symptom two years after acute infection was 59.7% for hospitalized patients, while the percentage of those who had not required hospitalization was 67.5%.November 16, 2022COVID-19French study confirms long COVID is a public health concernFrench researchers determined that in 10.1% of cases, patients were still suffering symptoms one year after their initial SARS-CoV-2 infection.November 10, 2022Healthcare ReformCDC’s five-day isolation period after COVID infection may not be sufficientStanford University researchers have published findings indicating that rapid antigen tests remained positive in 27% of the participants in a study after seven days of isolation.October 19, 2022COVID-19SARS-CoV-2 molecular tests highly accurate in Canadian studyThe diagnostic sensitivity of these molecular tests suggests that one negative test result can effectively rule out SARS-CoV-2 infection for most patients, the researchers said.October 12, 2022SequencingHarvard NGS technique sheds light on hard-to-isolate cellsThe technique is comparable to single-cell sequencing methods while simultaneously broadening the depth and scope of investigations possible on a tissue sample.October 11, 2022RUODuke University developing RNA-based probe for disease managementThe researchers contend that this tool could become a key technique in the managing of disease by simply modifying cells and their functions. It would offer a disease management tool that currently does not exist.October 7, 2022COVID-19UK researchers propose solution for meeting pandemic testing demandThe researchers are advocating the establishment of a system of reserve lab technicians and volunteers to handle the surge in testing that occurs during a pandemic.October 3, 2022InfectiousGerman study: self-testing effective in fighting SARS-CoV-2Successful long-term participation was highest among a group of study participants that took saliva-based tests.September 14, 2022Page 1 of 2Next PageTop StoriesCancerInvivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detectionUnder the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.Regulatory ApprovalSeegene obtains IVDR certification for 30 diagnostic assaysPolicy and RegulationAdvocacy groups in letter urge FDA to develop regulations for lab-developed testsCollaborationNucleai, Adlai Nortye collaborate on biomarkers for clinical trialsSponsor ContentVisit our Molecular Diagnostics Community
